About the Product

Description


Rocofite Injection contains Rocuronium 10mg, a non-depolarizing neuromuscular blocking agent used to induce muscle relaxation during surgical procedures and anesthesia. It allows controlled intubation and optimal surgical conditions.

Rocuronium works by competitively blocking acetylcholine at neuromuscular junctions, causing temporary paralysis of skeletal muscles. Its rapid onset and predictable duration make it preferred in operative settings.

Injection form ensures precise dosing, fast action, and reliable patient management during anesthesia. Its demand remains high in hospitals, surgical centers, and specialty clinics.

Adding Rocofite Injection to your anesthesia and surgery portfolio strengthens your product range with a high-demand, clinically trusted therapy. Its prescriber acceptance, institutional use, and export potential make it ideal for PCD pharma companies, distributors, and third-party manufacturing partners.

Common side effects may include mild hypotension, flushing, or transient changes in heart rate. Rare but serious side effects include allergic reactions, bronchospasm, prolonged paralysis, or respiratory depression. Immediate medical attention is required if severe reactions occur.

Rocofite Injection is indicated for muscle relaxation during surgery, facilitation of tracheal intubation, and mechanical ventilation in critically ill patients, as prescribed by a healthcare professional.

Rocofite Injection should only be administered by trained healthcare professionals in a controlled setting. Continuous monitoring of respiratory and cardiovascular function is essential. Use caution in patients with liver disease, neuromuscular disorders, or electrolyte imbalances.

Store Rocofite Injection in a cool, dry place, protected from light. Keep out of reach of children. Do not freeze and do not use if the solution appears discolored or contains particles.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Frequently Asked Questions